Discontinuation report GAVRETO
| Report ID | 242142 |
| Drug Identification Number | 02517590 |
| Brand name | GAVRETO |
| Common or Proper name | PRALSETINIB |
| Company Name | HOFFMANN-LA ROCHE LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | PRALSETINIB |
| Strength(s) | 100MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 120 Capsules |
| ATC code | L01EX |
| ATC description | |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2025-03-31 |
| Actual discontinuation date | |
| Remaining supply date | 2025-03-31 |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7070 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 5M8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2024-11-06 | French | Compare |
| v1 | 2024-11-06 | English | Compare |
Showing 1 to 2 of 2